Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo

Cellular Physiology and Biochemistry

Volumn 32, Issue 3, 2013, Pages 614-623

  Hou, Man ^a,b   Zhang, Nengwei ^c   Yang, Jingjing ^b   Meng, Xiangyu ^a,b   Yang, Ruan ^b   Li, Jian ^b   Sun, Tieying ^b,d  

^a Chinese Academy of Medical Sciences   (China)

^b BEIJING HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Akt; IDR 1; Inflammation; JNK; LL 37; MRSA

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; INNATE DEFENSE REGULATOR PEPTIDE IDR 1; INTERLEUKIN 6; PROTEIN KINASE B; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIMICROBIAL PEPTIDE IDR 1; JANUS KINASE; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; IN VIVO STUDY; LUNG LAVAGE; LUNG PARENCHYMA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SECTION; WESTERN BLOTTING; ANTIINFLAMMATORY ACTIVITY; CYTOKINE RELEASE; LUNG FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BRONCHOALVEOLAR LAVAGE FLUID; CATHELICIDINS; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PNEUMONIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884992610     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354465     Document Type: Article

References (38)

1. Li M, Du X, Villaruz AE, Diep BA, Wang D, Song Y, Tian Y, Hu J, Yu F, Lu Y, Otto M: MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat Med 2012;18: 816-819.
2. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK: Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298: 1763-1771.
3. Otto M: MRSA virulence and spread. Cell Microbiol 2012 Oct;14: 1513-1521.
4. Noore J, Noore A, Li B: Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus. Antimicrob Agents Chemother 2013;57: 1283-1290.
5. Larrick JW, Hirata M, Shimomoura Y, Yoshida M, Zheng H, Zhong J, Wright SC: Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother 1993;37: 2534-9.
6. Ruan Y, Shen T, Wang Y, Hou M, Li J, Sun T: Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages. Int Immunopharmacol 2013;15: 575-580.
7. Scott A, Weldon S, Buchanan PJ, Schock B, Ernst RK, McAuley DF, Tunney MM, Irwin CR, Elborn JS, Taggart CC: Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One 2011;6:e26525.
8. Nagant C, Pitts B, Nazmi K, Vandenbranden M, Bolscher JG, Stewart PS, Dehaye JP: Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments. Antimicrob Agents Chemother 2012;56: 5698-708.
9. Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL: Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 2004;172: 3070-3077.
10. Vandamme D, Landuyt B, Luyten W, Schoofs L: A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol 2012;280: 22-35.
11. Nijnik A, Madera L, Ma S, Waldbrook M, Elliott MR, Easton DM, Mayer ML, Mullaly SC, Kindrachuk J, Jenssen H, Hancock RE: Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J Immunol 2010;184: 2539-2550.
12. Cantley LC: The phosphoinositide 3-kinase pathway. Science 2002;296: 1655-1657.
13. Chan TO, Rittenhouse SE, Tsichlis PN: AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 1999;68: 965-1014.
14. Koyasu S. The role of PI3K in immune cells. Nat Immunol 2003;4: 313-319.
15. Lawlor MA, Alessi DR: PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci. 2001;114: 2903-2910.
16. Tachado SD, Samrakandi MM, Cirillo JD: Non-opsonic phagocytosis of Legionella pneumophila by macrophages is mediated by phosphatidylinositol 3-kinase. PLoS One 2008;3:e3324.
17. Guha M, Mackman N: The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002;277: 32124-32132.
18. Rincon M, Davis RJ: Regulation of the immune response by stress-activated protein kinases. Immunol Rev 2009;228: 212-224.
19. Kyriakis JM, Avruch J: Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012;92: 689-737.
20. Karin M, Gallagher E: From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005;57: 283-295.
21. Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11: 373-384.
22. Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81: 807-869.
23. Shaulian E, Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 2002;4:E131-136.
24. Hyam SR, Lee IA, Gu W, Kim KA, Jeong JJ, Jang SE, Han MJ, Kim DH: Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages. Eur J Pharmacol 2013;708: 21-29.
25. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, Rabe KF, Hiemstra PS: The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003;171: 6690-6696.
26. Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM: Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun 1999;67: 6084-6089.
27. Shen T, Aneas I, Sakabe N, Dirschinger RJ, Wang G, Smemo S, Westlund JM, Cheng H, Dalton N, Gu Y, Boogerd CJ, Cai CL, Peterson K, Chen J, Nobrega MA, Evans SM: Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. J Clin Invest 2011;121: 4640-4654.
28. Liu X, Shao K, Sun T: SIRT1 regulates the human alveolar epithelial A549 cell apoptosis induced by Pseudomonas aeruginosa lipopolysaccharide. Cell Physiol Biochem 2013;31: 92-101.
29. Chambers HF, Deleo FR: Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009;7: 629-641.
30. Nakamura A, Miyake K, Misawa S, Kuno Y, Horii T, Hori S, Kondo S, Tabe Y, Ohsaka A: Association between antimicrobial consumption and clinical isolates of methicillin-resistant Staphylococcus aureus: a 14-year study. J Infect Chemother 2012;18: 90-95.
31. Boman HG: Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003;254: 197-215.
32. Hancock RE, Sahl HG: Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006;24: 1551-1557.
33. Kirikae T, Hirata M, Yamasu H, Kirikae F, Tamura H, Kayama F, Nakatsuka K, Yokochi T, Nakano M: Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun 1998;66: 1861-1868.
34. Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock RE An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol 2007;25: 465-472.
35. Mansell A, Jenkins BJ: Dangerous liaisons between interleukin-6 cytokine and toll-like receptor families: A potent combination in inflammation and cancer. Cytokine Growth Factor Rev 2013;24: 249-56.
36. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11: 443-451.
37. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J: Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 2007;179: 3958-3965.
38. Lee HY, Bae YS: The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor. Biochem Biophys Res Commun 2008;369: 573-578.